{
    "title": "Gilead study: remdesivir has marginal benefit for moderate COVID patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8651987/Gilead-study-remdesivir-marginal-benefit-moderate-COVID-patients.html",
    "date": "2020-08-21",
    "keywords": [
        "drug",
        "beasley",
        "covid19",
        "course",
        "remdesivir",
        "benefit",
        "condition",
        "hospital",
        "analysis",
        "friday",
        "journal",
        "association",
        "moderatelyill",
        "improvement",
        "treatment",
        "importance",
        "emergency",
        "use",
        "authorization",
        "food",
        "administration",
        "disease",
        "coronavirus",
        "gilead",
        "month",
        "application",
        "fda",
        "approval",
        "trial",
        "recovery",
        "time",
        "forefront",
        "battle",
        "reporting",
        "deena",
        "tattersall"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}